Legis Daily

Empowering Pharmacists in the Fight Against Opioid Abuse Act

USA115th CongressHR-4275| House 
| Updated: 6/13/2018
Mark DeSaulnier

Mark DeSaulnier

Democratic Representative

California

Cosponsors (12)
Karen C. Handel (Republican)Elise M. Stefanik (Republican)Marsha Blackburn (Republican)David Rouzer (Republican)Greg Walden (Republican)Bruce Poliquin (Republican)Earl L. "Buddy" Carter (Republican)Greg Gianforte (Republican)Ann M. Kuster (Democratic)Mike Bost (Republican)Evan H. Jenkins (Republican)Jaime Herrera Beutler (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Empowering Pharmacists in the Fight Against Opioid Abuse Act (Sec. 2) This bill requires the Department of Health and Human Services (HHS) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal. HHS must seek input from relevant stakeholders.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 7, 2017
Introduced in House
Nov 7, 2017
Referred to the House Committee on Energy and Commerce.
Nov 10, 2017
Referred to the Subcommittee on Health.
Apr 25, 2018
Subcommittee Consideration and Mark-up Session Held.
Apr 25, 2018
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
May 9, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 9, 2018
Committee Consideration and Mark-up Session Held.
Jun 12, 2018
Mr. Walden moved to suspend the rules and pass the bill, as amended.
Jun 12, 2018
Considered under suspension of the rules. (consideration: CR H5066-5067)
Jun 12, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 4275.
Jun 12, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5066)
Jun 12, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5066)
Jun 12, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 13, 2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • November 7, 2017
    Introduced in House


  • November 7, 2017
    Referred to the House Committee on Energy and Commerce.


  • November 10, 2017
    Referred to the Subcommittee on Health.


  • April 25, 2018
    Subcommittee Consideration and Mark-up Session Held.


  • April 25, 2018
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • May 9, 2018
    Ordered to be Reported (Amended) by Voice Vote.


  • May 9, 2018
    Committee Consideration and Mark-up Session Held.


  • June 12, 2018
    Mr. Walden moved to suspend the rules and pass the bill, as amended.


  • June 12, 2018
    Considered under suspension of the rules. (consideration: CR H5066-5067)


  • June 12, 2018
    DEBATE - The House proceeded with forty minutes of debate on H.R. 4275.


  • June 12, 2018
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5066)


  • June 12, 2018
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5066)


  • June 12, 2018
    Motion to reconsider laid on the table Agreed to without objection.


  • June 13, 2018
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Crime and Law Enforcement

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
Drug trafficking and controlled substancesFraud offenses and financial crimesGovernment information and archivesHealth personnelHealth promotion and preventive carePrescription drugs

Empowering Pharmacists in the Fight Against Opioid Abuse Act

USA115th CongressHR-4275| House 
| Updated: 6/13/2018
Empowering Pharmacists in the Fight Against Opioid Abuse Act (Sec. 2) This bill requires the Department of Health and Human Services (HHS) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal. HHS must seek input from relevant stakeholders.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Nov 7, 2017
Introduced in House
Nov 7, 2017
Referred to the House Committee on Energy and Commerce.
Nov 10, 2017
Referred to the Subcommittee on Health.
Apr 25, 2018
Subcommittee Consideration and Mark-up Session Held.
Apr 25, 2018
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
May 9, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 9, 2018
Committee Consideration and Mark-up Session Held.
Jun 12, 2018
Mr. Walden moved to suspend the rules and pass the bill, as amended.
Jun 12, 2018
Considered under suspension of the rules. (consideration: CR H5066-5067)
Jun 12, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 4275.
Jun 12, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5066)
Jun 12, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5066)
Jun 12, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 13, 2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • November 7, 2017
    Introduced in House


  • November 7, 2017
    Referred to the House Committee on Energy and Commerce.


  • November 10, 2017
    Referred to the Subcommittee on Health.


  • April 25, 2018
    Subcommittee Consideration and Mark-up Session Held.


  • April 25, 2018
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • May 9, 2018
    Ordered to be Reported (Amended) by Voice Vote.


  • May 9, 2018
    Committee Consideration and Mark-up Session Held.


  • June 12, 2018
    Mr. Walden moved to suspend the rules and pass the bill, as amended.


  • June 12, 2018
    Considered under suspension of the rules. (consideration: CR H5066-5067)


  • June 12, 2018
    DEBATE - The House proceeded with forty minutes of debate on H.R. 4275.


  • June 12, 2018
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5066)


  • June 12, 2018
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5066)


  • June 12, 2018
    Motion to reconsider laid on the table Agreed to without objection.


  • June 13, 2018
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mark DeSaulnier

Mark DeSaulnier

Democratic Representative

California

Cosponsors (12)
Karen C. Handel (Republican)Elise M. Stefanik (Republican)Marsha Blackburn (Republican)David Rouzer (Republican)Greg Walden (Republican)Bruce Poliquin (Republican)Earl L. "Buddy" Carter (Republican)Greg Gianforte (Republican)Ann M. Kuster (Democratic)Mike Bost (Republican)Evan H. Jenkins (Republican)Jaime Herrera Beutler (Republican)

Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee

Crime and Law Enforcement

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug trafficking and controlled substancesFraud offenses and financial crimesGovernment information and archivesHealth personnelHealth promotion and preventive carePrescription drugs